Open AccessSecond Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia
Author(s) -
Reda Hemida,
Elvira L. Vos,
Basem El-Deek,
Mohammad Arafa,
Eman Toson,
Curt W. Burger,
Helena C. van Doorn
Publication year - 2019
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.664
H-Index - 220
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000003232
Subject(s) - medicine , curettage , chemotherapy , methotrexate , dilation and curettage , uterine perforation , gynecology , human chorionic gonadotropin , surgery , obstetrics , pregnancy , abortion , population , family planning , environmental health , biology , hormone , research methodology , genetics
To investigate the effect of second uterine curettage on the number of chemotherapy courses and relapse rate in low-risk postmolar gestational trophoblastic neoplasia.